The Journal of Bone and Joint Surgery (American) 86:2305-2318 (2004)
© 2004 The Journal of Bone and Joint Surgery, Inc.
Osteomyelitis in Long Bones
Luca Lazzarini, MD1,
Jon T. Mader, MD2 and
Jason H. Calhoun, MD3
1 Infectious Disease Unit, Department of Internal Medicine, San Bortolo
Hospital, Viale Rodolfi 47, 36100 Vicenza, Italy
2 Deceased
3 Department of Orthopaedic Surgery, University of Missouri, MC213, DC053.00,
One Hospital Drive, Columbia, MO 65212. E-mail address:
calhounj{at}health.missouri.edu
The authors did not receive grants or outside funding in support of their
research or preparation of this manuscript. They did not receive payments or
other benefits or a commitment or agreement to provide such benefits from a
commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, educational
institution, or other charitable or nonprofit organization with which the
authors are affiliated or associated.
Osteomyelitis in long bones remains challenging and expensive to treat,
despite advances in antibiotics and new operative techniques.
Plain radiographs still provide the best screening for acute and chronic
osteomyelitis. Other imaging techniques may be used to determine diagnosis and
aid in treatment decisions.
The decision to use oral or parenteral antibiotics should be based on
results regarding microorganism sensitivity, patient compliance, infectious
disease consultation, and the surgeon's experience. A suppressive antibiotic
regimen should be directed by the results of cultures.
Standard operative treatment is not feasible for all patients because of
the functional impairment caused by the disease, the reconstructive
operations, and the metabolic consequences of an aggressive therapy
regimen.
Operative treatment includes débridement, obliteration of dead
space, restoration of blood supply, adequate soft-tissue coverage,
stabilization, and reconstruction.

CiteULike Connotea Del.icio.us Facebook Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. P. Sedghizadeh, S. K.S. Kumar, A. Gorur, C. Schaudinn, C. F. Shuler, and J. W. Costerton
Microbial Biofilms in Osteomyelitis of the Jaw and Osteonecrosis of the Jaw Secondary to Bisphosphonate Therapy
J Am Dent Assoc,
October 1, 2009;
140(10):
1259 - 1265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. I Sealy, C. Nguyen, M. Tucci, H. Benghuzzi, and J. D Cleary
Delivery of Antifungal Agents Using Bioactive and Nonbioactive Bone Cements
Ann. Pharmacother.,
October 1, 2009;
43(10):
1606 - 1615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Pakos, H. D. Koumoulis, A. D. Fotopoulos, and J. P. A. Ioannidis
Osteomyelitis: Antigranulocyte Scintigraphy with 99mTc Radiolabeled Monoclonal Antibodies for Diagnosis Meta-Analysis
Radiology,
December 1, 2007;
245(3):
732 - 741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Z. JOHN, M. ALAGAPPAN, S. DEVADOSS, and A. DEVADOSS
Authors' reply
J Bone Joint Surg Br,
February 1, 2006;
88-B(2):
277 - 277.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. BISMIL, C. P. J. WOOD, and D. M. RICKETTS
A completely shattered tibia
J Bone Joint Surg Br,
February 1, 2006;
88-B(2):
276 - 277.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Makinen, M. Veiranto, P. Lankinen, N. Moritz, J. Jalava, P. Tormala, and H. T. Aro
In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler
J. Antimicrob. Chemother.,
December 1, 2005;
56(6):
1063 - 1068.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Letters to the Editor:
Read all Letters to the Editor
- Osteomyelitis, Current Concept Review
- John W. Thompson, M.D.
- JBJS Online, 6 Dec 2004
[Full text]
|